These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 12607332

  • 1. [Economic evaluation of H. pylori eradication].
    Ikeda S.
    Nihon Rinsho; 2003 Jan; 61(1):146-51. PubMed ID: 12607332
    [Abstract] [Full Text] [Related]

  • 2. The health economics of Helicobacter pylori infection.
    Moayyedi P.
    Best Pract Res Clin Gastroenterol; 2007 Jan; 21(2):347-61. PubMed ID: 17382282
    [Abstract] [Full Text] [Related]

  • 3. Cost-benefit analysis of testing for Helicobacter pylori in dyspeptic subjects.
    Sonnenberg A.
    Am J Gastroenterol; 1996 Sep; 91(9):1773-7. PubMed ID: 8792696
    [Abstract] [Full Text] [Related]

  • 4. Indications for treatment of Helicobacter pylori infection: a systematic overview.
    Veldhuyzen van Zanten SJ, Sherman PM.
    CMAJ; 1994 Jan 15; 150(2):189-98. PubMed ID: 8287341
    [Abstract] [Full Text] [Related]

  • 5. Immediate eradication of Helicobacter pylori in patients with previously documented peptic ulcer disease: clinical and economic effects.
    Fendrick AM, McCort JT, Chernew ME, Hirth RA, Patel C, Bloom BS.
    Am J Gastroenterol; 1997 Nov 15; 92(11):2017-24. PubMed ID: 9362183
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease.
    Wu CY, Kuo KN, Wu MS, Chen YJ, Wang CB, Lin JT.
    Gastroenterology; 2009 Nov 15; 137(5):1641-8.e1-2. PubMed ID: 19664631
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cost-effectiveness of population screening for Helicobacter pylori in preventing gastric cancer and peptic ulcer disease, using simulation.
    Roderick P, Davies R, Raftery J, Crabbe D, Pearce R, Patel P, Bhandari P.
    J Med Screen; 2003 Nov 15; 10(3):148-56. PubMed ID: 14561268
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Quality of life measurement clarifies the cost-effectiveness of Helicobacter pylori eradication in peptic ulcer disease and uninvestigated dyspepsia.
    Groeneveld PW, Lieu TA, Fendrick AM, Hurley LB, Ackerson LM, Levin TR, Allison JE.
    Am J Gastroenterol; 2001 Feb 15; 96(2):338-47. PubMed ID: 11232673
    [Abstract] [Full Text] [Related]

  • 12. [Indication of H. pylori eradication therapy--who should be treated?].
    Miwa H, Sato N.
    Nihon Rinsho; 2001 Feb 15; 59(2):301-7. PubMed ID: 11218402
    [Abstract] [Full Text] [Related]

  • 13. Benefits from elimination of Helicobacter pylori infection include major reduction in the incidence of peptic ulcer disease, gastric cancer, and primary gastric lymphoma.
    Graham DY.
    Prev Med; 1994 Sep 15; 23(5):712-6. PubMed ID: 7845945
    [Abstract] [Full Text] [Related]

  • 14. Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.
    Ando T, Minami M, Mizuno T, Watanabe O, Ishiguro K, Ina K, Kusugami K, Nobata K, Nishiwaki T, Tsuzuki T, Shimada M, El-Omar E, Goto H.
    Helicobacter; 2005 Oct 15; 10(5):379-84. PubMed ID: 16181347
    [Abstract] [Full Text] [Related]

  • 15. The role of screening for Helicobacter pylori in patients with duodenal ulceration in the primary health care setting.
    Rosengren H, Polson RJ.
    Br J Gen Pract; 1996 Mar 15; 46(404):177-9. PubMed ID: 8731626
    [Abstract] [Full Text] [Related]

  • 16. [Eradication of Helicobacter pylori in developing countries].
    Rollán A.
    Rev Med Chil; 1997 Aug 15; 125(8):939-49. PubMed ID: 9567401
    [Abstract] [Full Text] [Related]

  • 17. The effect of eradicating helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease.
    Take S, Mizuno M, Ishiki K, Nagahara Y, Yoshida T, Yokota K, Oguma K, Okada H, Shiratori Y.
    Am J Gastroenterol; 2005 May 15; 100(5):1037-42. PubMed ID: 15842576
    [Abstract] [Full Text] [Related]

  • 18. [Guidelines for the management of Helicobacter pylori--Maastricht III-2005 and Japanese guidelines].
    Kodama M, Murakami K, Okimoto T, Fujioka T.
    Nihon Rinsho; 2008 Apr 15; 66(4):804-10. PubMed ID: 18409534
    [Abstract] [Full Text] [Related]

  • 19. [Economic evaluation of Helicobacter pylori eradication for peptic ulcer disease in comparison with a conventional strategy in Japan].
    Ohara S.
    Nihon Rinsho; 2002 Feb 15; 60 Suppl 2():514-9. PubMed ID: 11979839
    [No Abstract] [Full Text] [Related]

  • 20. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S, Ittel TH, Wietholtz H.
    Z Gastroenterol; 2003 Aug 15; 41(8):719-28. PubMed ID: 12910426
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.